Wilmington, DE, United States of America

Mark A Wuonola

This inventor holds 9 USPTO granted patents. Top assignees: E.i. Dupont De Nemours and Company, Du Pont Merck Pharmaceutical, The Dupont Merck Pharmaceutical Company. Active years: 1977-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark A Wuonola. Retrieved from https://idiyas.com/inventor/mark-a-wuonola-ty1tbne1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 123(Granted Patents)


Location History:

  • Cambridge, MA (US) (1977)
  • Wilmington, DE (US) (1989 - 1991)

Company Filing History:


Years Active: 1977-1991

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mark A Wuonola

Introduction

Mark A Wuonola is a notable inventor based in Wilmington, DE (US), recognized for his significant contributions to the field of antibacterial compounds. With a total of nine patents to his name, Wuonola has made strides in developing innovative solutions that address critical health challenges.

Latest Patents

Among his latest patents are the Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives and the Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives. These compounds, such as l-N-[3-(2,3-dihydro-oxa or thio-lH-inden-5-yl)-2-oxooxazolidin-5-ylmethyl]acetamide, exhibit useful antibacterial activity. His work in this area highlights the potential for these derivatives to contribute to the development of effective antibacterial agents.

Career Highlights

Throughout his career, Wuonola has worked with prominent companies, including E.I. du Pont de Nemours and Company and Du Pont Merck Pharmaceutical. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in pharmaceuticals.

Collaborations

Some of his notable coworkers include Chia-Lin J Wang and Donnie Joe Sam. Their collaborative efforts have further advanced the research and development of innovative antibacterial compounds.

Conclusion

Mark A Wuonola's work exemplifies the impact of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to addressing health challenges through scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…